Literature DB >> 1703745

Henoch-Schöenlein syndrome in Qatar: the effects of steroid therapy and paucity of renal involvement.

S T Dawod1, K F Akl.   

Abstract

This is a retrospective study of 40 patients admitted to Hamad General Hospital in the state of Qatar between January 1983 and December 1987 with the diagnosis of Henoch-Schöenlein syndrome. Of the 40 patients, 25 were boys and 15 were girls, with a ratio of 1.6:1. Ages ranged from 2 years 3 months to 13 years, with a mean of 6 years. There were six episodes of recurrence in four patients. There was a clustering of cases in late summer and early winter. About half of the patients had a history of preceding upper respiratory infection. All of them had the typical skin rash. The percentages of joint, gastro-intestinal and renal manifestations were 80%, 65% and 17.39%, respectively. One patient had penile swelling which has not been reported before. Steroid therapy seemed to enhance early resolution of abdominal pain but did not affect the course of the syndrome. Sixty-seven per cent of the patients were followed up for from 4 weeks to 5 years, with a mean of 8 months. Only one patient with renal involvement continued to have proteinuria with microscopic haematuria and hypertension. The rest were normal within about 2 months. The remarkably low incidence of renal involvement in our study may be related to local variations in causative factors. Henoch-Schöenlein syndrome is a milder disease in Qatar than in other countries.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1703745     DOI: 10.1080/02724936.1990.11747443

Source DB:  PubMed          Journal:  Ann Trop Paediatr        ISSN: 0272-4936


  7 in total

Review 1.  Adjuvant treatments for Henoch-Schönlein purpura nephritis in children: A systematic review.

Authors:  Marco Zaffanello; Milena Brugnara; Massimo Franchini; Vassilios Fanos
Journal:  Curr Ther Res Clin Exp       Date:  2009-06

2.  Nationwide epidemiological survey of childhood IgA vasculitis associated hospitalization in the USA.

Authors:  Yusuke Okubo; Kotaro Nochioka; Hiroshi Sakakibara; Hiroshi Hataya; Toshiro Terakawa; Marcia Testa; Robert P Sundel
Journal:  Clin Rheumatol       Date:  2016-09-05       Impact factor: 2.980

Review 3.  Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review.

Authors:  H Narchi
Journal:  Arch Dis Child       Date:  2005-05-04       Impact factor: 3.791

Review 4.  Effects of corticosteroid on Henoch-Schönlein purpura: a systematic review.

Authors:  Pamela F Weiss; James A Feinstein; Xianqun Luan; Jon M Burnham; Chris Feudtner
Journal:  Pediatrics       Date:  2007-11       Impact factor: 7.124

5.  Prediction of total body water in infants and children.

Authors:  J C K Wells; M S Fewtrell; P S W Davies; J E Williams; W A Coward; T J Cole
Journal:  Arch Dis Child       Date:  2005-09       Impact factor: 3.791

6.  Henoch schonlein purpura--a 5-year review and proposed pathway.

Authors:  Louise Watson; Amanda R W Richardson; Richard C L Holt; Caroline A Jones; Michael W Beresford
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

7.  Penile Skin Involvement as the First Presentation of Henoch-Schonlein Purpura Report of Nine Cases and Review of Literature.

Authors:  Koosha Paydary; Sahra Emamzadeh Fard; Amir Hassan Mahboubi; Vahid Ziaee; Mohammad Hassan Moradinejad; Abdol-Mohammad Kajbafzadeh
Journal:  Iran J Pediatr       Date:  2015-08-24       Impact factor: 0.364

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.